glp 1 and biologics New Molecules Emerging Indications for GLP-1 Medicines Color coding GLP-1 and Inflammation: How These

A history of pancreatitis should prompt careful riskbenefit assessment and close monitoring rather than being considered an absolute contraindication to GLP-1 RA therapy

For GLP-1 receptor agonists, the most common side effects include nausea, vomiting, and mild diarrhea

Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial

Conflict of interest Author AA has received consulting fees from AbbVie, Allergan, Amgen, Arena, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Celltrion, Eli-Lilly, Ferring, Galapagos, Gilead, Janssen, MSD, Mylan, Pfizer, Protagonist Therapeutics, Roche, Samsung Bioepis, Sandoz and Takeda

Allow time for your body to adjust